Farhan Chughtai

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 5

Top Topics

Magnetic Resonance Imaging

Tyrosine Kinase

Chronic Myeloid Leukemia

Ejection Fraction

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Simone Claudiani, Farhan Chughtai, Afzal Khan, Chloe Hayden, Fiona Fernando, Jamshid S Khorashad, Victoria Orovboni, Glenda Scandura, Andrew J Innes, Jane F Apperley, Dragana Milojkovic
Long-term outcomes after upfront second-generation tyrosine kinase inhibitors for chronic myeloid leukemia: managing intolerance and resistance. Leukemia 38 (4) (2024)
Simone Claudiani, Farhan Chughtai, Afzal Khan, Chloe Hayden, Fiona Fernando, Jamshid S Khorashad, Victoria Orovboni, Glenda Scandura, Andrew J Innes, Jane F Apperley, Dragana Milojkovic
Long-term outcomes after upfront second-generation tyrosine kinase inhibitors for chronic myeloid leukemia: managing intolerance and resistance. Leukemia 38 (4) (2024)
Simone Claudiani, Farhan Chughtai, Afzal Khan, Chloe Hayden, Fiona Fernando, Jamshid S Khorashad, Victoria Orovboni, Glenda Scandura, Andrew J Innes, Jane F Apperley, Dragana Milojkovic
Long-term outcomes after upfront second-generation tyrosine kinase inhibitors for chronic myeloid leukemia: managing intolerance and resistance. Leukemia 38 (4) (2024)
Simone Claudiani, Farhan Chughtai, Afzal Khan, Chloe Hayden, Fiona Fernando, Jamshid S Khorashad, Victoria Orovboni, Glenda Scandura, Andrew J Innes, Jane F Apperley, Dragana Milojkovic
Long-term outcomes after upfront second-generation tyrosine kinase inhibitors for chronic myeloid leukemia: managing intolerance and resistance. Leukemia 38 (4) (2024)
Simone Claudiani, Farhan Chughtai, Afzal Khan, Chloe Hayden, Fiona Fernando, Jamshid S Khorashad, Victoria Orovboni, Glenda Scandura, Andrew J Innes, Jane F Apperley, Dragana Milojkovic
Long-term outcomes after upfront second-generation tyrosine kinase inhibitors for chronic myeloid leukemia: managing intolerance and resistance. Leukemia (2024)